In recent years, CDH17 has attracted attention as a sensitive and specific biomarker for gastric, colorectal, and pancreatic cancers, outperforming other frequently used targets such as cytokeratin 20 (CK20) and the CDX2 gene [8]. Here, KRT20 is linked to pancreatic neoplasm.